Literature DB >> 15048080

Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation.

Yasushi Yatabe1, Tetsuya Mitsudomi, Takashi Takahashi.   

Abstract

Maspin has been demonstrated to be a suppressor of invasion and cell motility in vitro, whereas in vivo analyses have reported that increased expression of maspin is associated with malignant behavior. The present study examined maspin expression in normal lung and non-small-cell lung cancers. Only proximal airway cells in the normal lung expressed maspin, and the expression was associated with decreased methylation. This association was also observed in non-small-cell lung cancers, but the expression was quite different among histologic subtypes; 20 of 21 squamous cell carcinomas showed intense, uniform expression, whereas the expression status varied among adenocarcinomas. Of the 119 adenocarcinomas, 60 were negative, 23 positive and 36 showed a heterogeneous expression pattern. The expression was inversely correlated with markers of peripheral airway cells. Taken together, the results suggest that maspin may be expressed in association with the proximal airway cell type. It is of note that the heterogeneous expression pattern of maspin is quite distinctive, showing geographic positivity in the individual tumors. Separate analysis of methylation status in positive and negative portions of individual tumors provided an instance of intratumor diversity associated with promoter DNA methylation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048080     DOI: 10.1038/sj.onc.1207557

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Clinical relevance of maspin expression in bladder cancer.

Authors:  Wolf-D Beecken; Tobias Engl; Knut Engels; Christa Blumenberg; Elsie Oppermann; Kevin Camphausen; Yuen Shing; Gerd Reinecke; Dietger Jonas; Roman Blaheta
Journal:  World J Urol       Date:  2006-07-11       Impact factor: 4.226

Review 2.  Maspin: the new frontier.

Authors:  Zhila Khalkhali-Ellis
Journal:  Clin Cancer Res       Date:  2006-12-15       Impact factor: 12.531

3.  Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer.

Authors:  Matthias Woenckhaus; Lukas Bubendorf; Peter Dalquen; Julia Foerster; Hagen Blaszyk; Martina Mirlacher; Markus Soler; Wolfgang Dietmaier; Guido Sauter; Arndt Hartmann; Peter J Wild
Journal:  J Clin Pathol       Date:  2006-05-12       Impact factor: 3.411

Review 4.  Connections between epigenetic gene silencing and human disease.

Authors:  Timothy J Moss; Lori L Wallrath
Journal:  Mutat Res       Date:  2007-01-21       Impact factor: 2.433

5.  Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.

Authors:  Dengfeng Cao; Robb E Wilentz; James L Abbruzzese; Linus Ho; Anirban Maitra
Journal:  Int J Gastrointest Cancer       Date:  2005

6.  Epigenetic regulation of the cell type-specific gene 14-3-3sigma.

Authors:  Marc M Oshiro; Bernard W Futscher; Aaron Lisberg; Ryan J Wozniak; Walter T Klimecki; Frederick E Domann; Anne E Cress
Journal:  Neoplasia       Date:  2005-09       Impact factor: 5.715

7.  DNA Methylation Profiles of Protease Nexin 1 (SERPINE2) Gene in Human Cell Lines.

Authors:  Shan Gao; Peter A Andreasen
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

8.  Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.

Authors:  Mark A Horswill; Malathi Narayan; Debra J Warejcka; Lisa A Cirillo; Sally S Twining
Journal:  Exp Eye Res       Date:  2008-01-12       Impact factor: 3.467

9.  Decreased maspin combined with elevated vascular endothelial growth factor C is associated with poor prognosis in non-small cell lung cancer.

Authors:  Xing Wang; Yang Wang; Shaolei Li; Bin Dong; Qingfeng Zheng; Shi Yan; Yuanyuan Ma; Jianzhi Zhang; Jian Fang; Nan Wu; Huijuan Wu; Yue Yang
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

10.  High frequency of coexpression of maspin with p63 and p53 in squamous cell carcinoma but not in adenocarcinoma of the lung.

Authors:  Bonnie Choy; Jennifer J Findeis-Hosey; Faqian Li; Loralee A McMahon; Qi Yang; Haodong Xu
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.